Jan 31, 2017 12:01 pm UTC| Business
YAVNE, Israel, Jan. 31, 2017 -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces final...
Jan 31, 2017 12:01 pm UTC| Business
YAVNE, Israel, Jan. 31, 2017 -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces final...
Jan 31, 2017 12:01 pm UTC| Business
HOUSTON, Jan. 31, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited...
Jan 31, 2017 12:01 pm UTC| Business
HOUSTON, Jan. 31, 2017 -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited...
Jan 31, 2017 12:01 pm UTC| Business
– First Patient Treated with Non-viral Sleeping Beauty Modified CAR-T Cells Produced in 2 Weeks – Anticipate Phase 1 Clinical Trial Launch in 2017 with Administration of Sleeping Beauty CAR-T Cells Produced within 2 Days–...
Jan 31, 2017 12:01 pm UTC| Business
– First Patient Treated with Non-viral Sleeping Beauty Modified CAR-T Cells Produced in 2 Weeks – Anticipate Phase 1 Clinical Trial Launch in 2017 with Administration of Sleeping Beauty CAR-T Cells Produced within 2 Days–...
Jan 31, 2017 12:01 pm UTC| Business
SANTA MONICA, Calif., Jan. 31, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...